Related Experiment Video
Updated: Sep 14, 2026

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
Published on: November 16, 2012
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain
M R Popoff1, E J Rubin, D M Gill
1Unité des Antigènes Bactériens, UA Centre National de la Recherche Scientifique, Paris, France.
Abstract:
By screening possible ADP-ribosyltransferase activities in culture supernatants from various Clostridium species, we have found one Clostridium difficile strain (CD196) (isolated in our laboratory) that is able to produce, in addition to toxins A and B, a new ADP-ribosyltransferase that was shown to covalently modify cell actin as Clostridium botulinum C2 or Clostridium perfringens E iota toxins do. The molecular weight of the CD196 ADP-ribosyltransferase (CDT) was determined to be 43 kilodaltons, and its isoelectric point was 7.8. No cytotoxic activity on Vero cells or lethal activity upon injection in mice was associated with this enzyme. CDT was neither related to C. difficile A or B toxins nor to C. botulinum C2 toxin component I. However, Vero cells cultivated in the presence of C. difficile B toxin had a lower amount of actin able to be ADP-ribosylated by CDT or C2 toxin in vitro. Antibodies raised against CDT reacted by immunoblot analysis with a 43-kilodalton protein of C. perfringens type E culture supernatant producing the iota toxin.
Insights
A new ADP-ribosyltransferase (CDT) from Clostridium difficile modifies cell actin, similar to other toxins. This enzyme lacks direct toxicity but impacts actin modification in cells treated with C. difficile toxin B.
Area of Science:
- Microbiology
- Molecular Biology
- Toxicology
Background:
- Clostridium species produce various toxins affecting host cells.
- ADP-ribosyltransferases are enzymes that modify cellular proteins, impacting cell function.
- Clostridium difficile toxins A and B are well-known virulence factors.
Purpose of the Study:
- To screen Clostridium species for novel ADP-ribosyltransferase activities.
- To characterize a newly identified ADP-ribosyltransferase from Clostridium difficile.
- To investigate the relationship between this enzyme and known toxins.
Main Methods:
- Screening of culture supernatants from Clostridium species.
- Biochemical characterization of the novel ADP-ribosyltransferase (molecular weight, isoelectric point).
- Assays for cytotoxic and lethal activity.
- In vitro ADP-ribosylation assays using cell actin.
- Immunoblot analysis with antibodies against the novel enzyme.
Main Results:
- A novel ADP-ribosyltransferase (CDT) was identified in Clostridium difficile strain CD196.
- CDT (43 kDa, pI 7.8) covalently modifies cell actin.
- CDT showed no direct cytotoxic or lethal activity.
- CDT is distinct from C. difficile toxins A and B, and C. botulinum C2 toxin component I.
- Pre-treatment of Vero cells with C. difficile toxin B reduced actin's ADP-ribosylation by CDT.
- Antibodies to CDT recognized a similar protein in Clostridium perfringens type E supernatant.
Conclusions:
- Clostridium difficile produces a novel actin-modifying ADP-ribosyltransferase, CDT.
- CDT's activity is distinct from known C. difficile toxins but may be influenced by Toxin B.
- CDT shares antigenic similarities with the iota toxin component from Clostridium perfringens type E.
Related Concept Videos
Cytoskeletal Proteins in Bacteria
Introduction to Actin
Actin Polymerization
The nucleation phase involves forming a stable nucleus consisting of three actin monomers to form a new actin filament. Actin-binding proteins such as formins and Arp2/3 complex help filament growth post-nucleation. The Formins form straight actin...
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
GPCRs Regulate Adenylyl Cylase Activity
Two...
Bacterial Phylum Actinobacteria

